Randomized controlled trialHumanClinical Trial, Phase III
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
JAMA, 2024 Jan 2. Aronne LJ, Sattar N, Horn DB and 10 others.
Study type
Randomized controlled trial · Clinical Trial, Phase III
Subjects
Human participants (PubMed MeSH: Humans)
Journal
JAMA
Published
2024 Jan 2
PubMed
Indexed under
MeSH terms assigned by the National Library of Medicine.
AdultFemaleHumansMaleMiddle AgedDouble-Blind MethodGastric Inhibitory PolypeptideObesityOverweightTreatment OutcomeWeight LossGlucagon-Like Peptide-2 Receptor
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page